Screener
R&D at other companies
Other financials
Where this comes from
Reported directly by Kodiak Sciences Inc in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211951
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Operating expenses | ||
| Research and development | $48,547 | $43,644 |
| General and administrative | 11,230 | 15,429 |
| Total operating expenses | 59,777 | 59,073 |
| Loss from operations | (59,777) | (59,073) |
| Interest income | 1,641 | 1,602 |
| Other income (expense), net | (22) | 10 |
| Net loss and comprehensive loss | $(58,158) | $(57,461) |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Kodiak Sciences Inc's R&D?
- Kodiak Sciences Inc (KOD) reported R&D of $48.55M in Q1 2026.
- How has Kodiak Sciences Inc's R&D changed year-over-year?
- Kodiak Sciences Inc's R&D increased by 11.2% year-over-year, from $43.64M to $48.55M.
- What is the long-term trend for Kodiak Sciences Inc's R&D?
- Over 4 years (2021 to 2025), Kodiak Sciences Inc's R&D has grown at a -4.3% compound annual growth rate (CAGR), from $217.34M to $182.37M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Kodiak Sciences Inc's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude